Management of hereditary angioedema
Art & Science Previous     Next

Management of hereditary angioedema

John Dempster Senior clinical nurse specialist, The Royal London Hospital, London

Hereditary angioedema is characterised by unpredictable, painful and potentially life-threatening oedema. Recently, some C1 inhibitors have been approved for self-administration and/or routine prevention, enabling patients to be proactive in managing their disease and reducing the burden of illness. This article discusses the effect of these advances from a specialist nurse’s perspective.

Nursing Standard. 27, 37,35-40. doi: 10.7748/ns2013.05.27.37.35.e7336

Correspondence

john.dempster@bartshealth.nhs.uk

Peer review

This article has been subject to double blind peer review

Conflict of interest

The author has performed consultancy work for CSL Behring, Shire and ViroPharma. Medical writing assistance was provided by Shilpa Aggarwal, ApotheCom ScopeMedical, funded by ViroPharma Ltd.

Accepted: 14 January 2013